Skip to search formSkip to main contentSkip to account menu

sp100 antigen

Known as: sp100 
National Institutes of Health

Related topics

Related topics

3 relations
SP100 genesp100 Ab:PrThr:Pt:Ser:Ordsp100 Ab:PrThr:Pt:Ser:Ord:IB

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Retraction: Sp100 as a potent tumor suppressor: accelerated senescence and rapid malignant transformation of human fibroblasts through modulation of an embryonic stem cell program.
The authors wish to retract the article entitled "Sp100 as a Potent Tumor Suppressor: Accelerated Senescence and Rapid Malignant… 
Highly Cited
2013
Highly Cited
2013
Sp100 Provides Intrinsic Immunity against Human Papillomavirus Infection
ABSTRACT Most DNA viruses associate with, and reorganize, nuclear domain 10 (ND10) bodies upon entry into the host nucleus. In… 
2012
2012
Epitope‐specific anti‐nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine‐dependent
Although the hallmark of primary biliary cirrhosis (PBC) is the presence of anti‐mitochondrial antibodies (AMA), a significant… 
2011
2011
Cdc20 mediates D-box-dependent degradation of Sp100.
Highly Cited
2011
Highly Cited
2011
SUMO Pathway Dependent Recruitment of Cellular Repressors to Herpes Simplex Virus Type 1 Genomes
Components of promyelocytic leukaemia (PML) nuclear bodies (ND10) are recruited to sites associated with herpes simplex virus… 
Highly Cited
2007
Highly Cited
2007
Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation
The ubiquitin‐related modifier SUMO regulates a wide range of cellular processes by post‐translational modification with one, or… 
2001
2001
Evidence for separate ND10-binding and homo-oligomerization domains of Sp100.
Nuclear domains called ND10 or PML nuclear bodies consist of an aggregation of several proteins, most notably PML and Sp100. PML… 
Highly Cited
1999
Highly Cited
1999
Viral Immediate-Early Proteins Abrogate the Modification by SUMO-1 of PML and Sp100 Proteins, Correlating with Nuclear Body Disruption
ABSTRACT PML nuclear bodies (NBs) are subnuclear structures whose integrity is compromised in certain human diseases, including… 
Highly Cited
1997
Highly Cited
1997
Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1
PML and Sp100 proteins are associated with nuclear domains, known as nuclear dots (NDs). They were discovered in the context of… 
Highly Cited
1992
Highly Cited
1992
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis.
About 30% of patients suffering from the chronic autoimmune liver disease primary biliary cirrhosis produce autoantibodies… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)